Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MOTS | Common Stock, par value $0.0001 per share | Award | $0 | +175K | +36.25% | $0.00 | 658K | Feb 10, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MOTS | Stock Option (right to buy) | Award | $0 | +175K | $0.00 | 175K | Feb 10, 2022 | Common Stock, par value $0.0001 per share | 175K | $0.46 | Direct | F2 |
Id | Content |
---|---|
F1 | On February 10, 2022, Reporting Person was granted 175,000 Common Stock restricted stock units. The restricted stock units vest in a series of twelve (12) successive substantially equal quarterly installments, with the first installment vesting on May 1, 2022 and continuing the first day of each third month thereafter. Each restricted stock unit represents a contingent right to receive one share of Common Stock. The restricted stock units award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "2016 Plan"). |
F2 | The option award was made in accordance with the terms of the 2016 Plan. The option vests in a series of twelve (12) successive substantially equal quarterly installments, with the first installment vesting on May 1, 2022 and continuing the first day of each third month thereafter. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan. |